Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-019211
Filing Date
2017-07-27
Accepted
2017-07-27 18:29:19
Documents
2
Period of Report
2017-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4008
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4535
  Complete submission text file 0000899243-17-019211.txt   9897
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOKAI PHARMACEUTICALS, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Morrison Jodie Pope (Reporting) CIK: 0001618247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 17987395